INJECTABLE PHENYLEPHRINE COMPOSITIONS

Patent Number: WO-2024008865-A1

Publication Year: 2024

Application Year: 2023

Priority Year: 2022

Jurisdictions: WO

Status: N/A

Inventors:

SIMAC MATIJA

Applicants:

  1. Xellia (Denmark)
  2. [NORA names: Xellia; Private Research]

Abstract

Described herein is a product including a ready-to-administer injectable formulation, the formulation including phenylephrine or a pharmaceutically acceptable salt thereof, a tonicity agent and a pH adjusting agent, wherein the pH adjusting agent is tartaric acid; and wherein the formulation of this oxygen sensitive substance is stable for prolonged period of times even when manufactured without protection from oxygen and when packed and stored in a flexible plastic container without modification of atmosphere by oxygen removal from the bag or the overwrap.

Patent Family Records (1)

INJECTABLE PHENYLEPHRINE COMPOSITIONS

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) SIMAC MATIJA

2024, WO-2024008865-A1

Data Provider: Digital Science